The combination of Erleada, Zytiga and the steroid prednisone was associated with a trend toward better survival outcomes in certain patients with chemotherapy-naive metastatic castration-resistant ...
Lynparza, Zytiga and prednisone led to improved progression-free survival and response rates in patients with metastatic prostate cancer. The drug combination of Lynparza (olaparib), Zytiga ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results